Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2
DISCLOSURES Cindy Wassef, Radhika Shah, Mahin Alamgir, Samantha Ouellette, and Giulia Frias have no conflicts of interest to disclose
Wegovy (semaglutide) doesnt carry this warning
If you wait too long to engage your provider, you may have to go all the way back to your initial starting dose. What can you do if your medicine is not available
It has been suggested that SGLT2-i could exert a RAS-inhibition-like effect, without being associated with a real RAS-suppression
Ocular complications from glucagon-like peptide-1 receptor agonists: Clinical evidence, potential mechanisms, and clinical recommendations